Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Knoxville, TN
SEC filing record 1 source field available
Fiscal year end
31 December
PROVECTUS BIOPHARMACEUTICALS, INC. has filed 1,077 SEC EDGAR filings since 31 Mar 2000

SEC filing history

Showing 476-500 of 803 matching filings.

Per page
25
Current page
20
CORRESP

CORRESP filing

Filing date
13 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
12 Jan 2016
Reporting date
12 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-I File 005-32172

SC TO-I

Filing date
31 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-4 File 333-208816

S-4

Filing date
31 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Dec 2015
Reporting date
21 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
16 Dec 2015
Reporting date
16 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Dec 2015
Reporting date
09 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Dec 2015
Reporting date
09 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Dec 2015
Reporting date
09 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Dec 2015
Reporting date
09 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Dec 2015
Reporting date
09 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Dec 2015
Reporting date
09 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Dec 2015
Reporting date
09 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
05 Nov 2015
Reporting date
05 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
05 Nov 2015
Reporting date
05 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
20 Oct 2015
Reporting date
20 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
02 Oct 2015
Reporting date
01 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
29 Sep 2015
Reporting date
29 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
23 Sep 2015
Reporting date
23 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
21 Sep 2015
Reporting date
21 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36457

DEF 14A

Filing date
01 Sep 2015
Reporting date
01 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-36457

PRE 14A

Filing date
21 Aug 2015
Reporting date
01 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
18 Aug 2015
Reporting date
18 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
06 Aug 2015
Reporting date
06 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .